AMARIN CORP PLC\UK Derivative Liability, Current
AMARIN CORP PLC\UK (AMRN) had Derivative Liability, Current of $100.00 thousand as of 2014-12-31, per its 10-Q filed 2015-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2015-11-04
- 2014-12-31: Derivative Liability, Current $100.00K; Derivative Liability, Current as first filed $119.00K.
- 2014-09-30: Derivative Liability, Current $121.00K.
- 2013-12-31: Derivative Liability, Current $6.89M.
- 2009-10-31: Derivative Liability, Current $48.30M.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2014-12-31 | $100.00K 10-Q · filed 2015-11-04 | $119.00K 10-K · filed 2015-03-03 |
| 2014-09-30 | $121.00K 10-Q · filed 2014-11-06 | |
| 2013-12-31 | $6.89M 10-K · filed 2015-03-03 | |
| 2009-10-31 | $48.30M 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |